The U.S. Food and Drug Administration this week approved Descovy as a second PrEP drug for at-risk adults, except for those who have receptive vaginal sex. The announcement arrives ahead of PrEP drug Truvada going generic next year.
Is Truvada enough to fight HIV? That question was left to five debaters, including Kink.com's Peter Acworth and AIDS Healthcare Foundation's Michael Weinstein, who offered their own takes on the question to The New York Times this evening.
